Learn more

HANNOVER MED HOCHSCHULE

Overview
  • Total Patents
    188
  • GoodIP Patent Rank
    56,156
About

HANNOVER MED HOCHSCHULE has a total of 188 patent applications. Its first patent ever was published in 2001. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and Germany. Its main competitors in its focus markets biotechnology, pharmaceuticals and medical technology are NAT UNIV CORP TOKYO MED & DENT, NAT CANCER CT and MOUNT SINAI HOSPITAL CORP.

Patent filings per year

Chart showing HANNOVER MED HOCHSCHULEs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Vogt Peter 11
#2 Witte Torsten 10
#3 Wollert Kai Christoph 10
#4 Thum Thomas 9
#5 Allmeling Christina 8
#6 Ganser Arnold 8
#7 Hennig Christian 7
#8 Gerardy-Schahn Rita 7
#9 Drexler Helmut 7
#10 Lenarz Thomas 7

Latest patents

Publication Filing date Title
EP3072900A1 Anti-tumour medicament based on adenovirus
WO2015132158A1 Medical implant, medical device and method for making a medical implant
DE102015101810A1 Method for producing a component by means of a generative manufacturing process, installation for producing a component by means of a generative manufacturing process and patient-specific generated medical implant
EP2939690A1 Vaccine
US2016177391A1 Analysis for takotsubo cardiomyopathy by means of differentially regulated microrna molecules
EP2996692A2 Means and methods for treating cancer
EP2921561A1 Mitochondrial non-coding RNAs for predicting disease progression in heart failure and myocardial infarction patients
CN110903378A Factor1 protein, factor 2 protein and inhibitors thereof for treating or preventing diseases
WO2014079966A1 Analysis for adult-onset still's disease
EP2816354A1 Biomarker for complex regional pain syndrome (CRPS)
WO2014121840A1 Induced dendritic cells and uses thereof
EP2617382A2 Dental curette
DE102012112600A1 Method for determining the degree of immunosuppression in a subject and application thereof
WO2013010660A1 Enzymes having alpha2,9 endosialidase activity
EP2623122A1 Coated devices and methods for coating
DE102011122227A1 Method and device for producing a bioartificial tissue construct
EP2597463A1 Methods of enrichment and isolation of regulatory T-cells and use of the same
EP2592145A1 Medicament for the treatment of cardiac disease
DE102011054821A1 Device combination for connecting hollow organs (anastomosis)
WO2012045756A1 Process for producing three-dimensional tissue